Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13002960 | 1.00 | CTDSP1 (0.43) | CTDSP1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL13002961 | 0.89 | POLB (0.48) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL13002962 | 0.85 | ALDH1A1 (0.60) | ALDH1A1HPGDL3MBTL1MAPTTDP1 | |
| SCHEMBL12810186 | 0.80 | TP53 (0.43) | ALDH1A1HPGDKMT2AL3MBTL1TSHR | |
| SCHEMBL1135159 | 0.80 | TP53 (0.43) | ALDH1A1HPGDKMT2AL3MBTL1TSHR | |
| SCHEMBL12879317 | 0.78 | PTPN1 (0.49) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL12810187 | 0.75 | POLB (0.48) | CTDSP1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL13002954 | 0.72 | NPC1 (0.52) | ALDH1A1MEN1KMT2AMAPTTSHR | |
| SCHEMBL13002948 | 0.72 | LMNA (0.57) | ALDH1A1MEN1KMT2AL3MBTL1MAPT | |
| SCHEMBL1135097 | 0.72 | NPC1 (0.52) | ALDH1A1MEN1KMT2AMAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436115-B2 | Catalyst systems based on carbonylamino fulvenes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2013-05-07 | — | — | US | disclosed |
| EP-2167517-B1 | CATALYSTS SYSTEMS BASED ON CARBONYLAMINO FULVENES | TOTAL PETROCHEMICALS RES FELUY (BE) | 2011-02-23 | — | — | EP | disclosed |
| US-20100311931-A1 | Catalyst Systems Based on Carbonylamino Fulvenes | TOTAL PETROCHEMICALS RESEARCH FELUY | 2010-12-09 | — | — | US | disclosed |
| EP-2167517-A2 | CATALYSTS SYSTEMS BASED ON CARBONYLAMINO FULVENES | Total Petrochemicals Research Feluy (BE) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009013196-A2 | CATALYSTS SYSTEMS BASED ON CARBONYLAMINO FULVENES | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2009-01-29 | — | — | WO | disclosed |
| EP-2019110-A1 | Catalysts systems based on carbonylamino fulvenes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2009-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311931-A1 | Catalyst Systems Based on Carbonylamino Fulvenes | CYCS, FOS, COPE | CTDSP1 2136/4885ALDH1A1 1863/4885HPGD 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.